Format

Send to

Choose Destination
Int J Epidemiol. 2019 Apr 10. pii: dyz062. doi: 10.1093/ije/dyz062. [Epub ahead of print]

Measles, mumps and rubella vs diphtheria-tetanus-acellular-pertussis-inactivated-polio-Haemophilus influenzae type b as the most recent vaccine and risk of early 'childhood asthma'.

Author information

1
Research Center for Vitamins and Vaccines (CVIVA), Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark.
2
Section of Epidemiology, Department of Public Health, The University of Copenhagen, Copenhagen, Denmark.
3
Depertment of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark.
4
OPEN, Odense University Hospital/Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
5
Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
6
Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
7
Center for Statistical Science, Peking University, Beijing, China.
8
Department of Clinical Epidemiology, Aarhus University, Aarhus N, Denmark.

Abstract

BACKGROUND AND OBJECTIVE:

Live vaccines may have beneficial non-specific effects. We tested whether the live measles, mumps and rubella (MMR) vaccine compared with the non-live diphtheria-tetanus-acellular-pertussis-inactivated-polio-Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine as the most recent vaccine was associated with less childhood asthma and fewer acute hospital contacts for childhood asthma among boys and girls.

METHODS:

This study is a nationwide register-based cohort study of 338 761 Danish children born between 1999 and 2006. We compared (i) the incidence of first-registered childhood asthma based on hospital contacts and drug prescriptions and (ii) the incidence of severe asthma defined as acute hospital contacts for childhood asthma between the ages of 15 and 48 months among children whose last received vaccine was three doses of DTaP-IPV-Hib and then MMR with children whose last received vaccine was three doses of DTaP-IPV-Hib.

RESULTS:

For boys, following the recommended vaccine schedule of MMR after DTaP-IPV-Hib3 compared with DTaP-IPV-Hib3 as the last received vaccine, MMR was associated with 8.1 (95% confidence interval 3.9-12.3) fewer childhood asthma cases per 1000 boys, corresponding to 10% (5-15%) reduction in the cumulative incidence of childhood asthma. MMR, when given last, was also associated with 16.3 (95% confidence interval 12.7-20.0) fewer acute hospital admissions for childhood asthma per 1000 boys, corresponding to a 27% (22-31%) reduction in the cumulative incidence. No associations were seen for girls.

CONCLUSION:

MMR may have a protective effect against childhood asthma for boys. This calls for an understanding of whether non-specific effects of vaccines can be used to optimize our vaccine programmes.

KEYWORDS:

Asthma; asthma; heterologous; immunity; immunization; infant; measles; mumps and rubella vaccine; non-specific effects of vaccines; trained innate immunity; vaccine sequence

PMID:
31062020
DOI:
10.1093/ije/dyz062

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center